Evidence map›Paper›PMID 33178043›Full record

ArticleFrontiers in physiology2020

Epicardial Adipose Tissue and IL-13 Response to Myocardial Injury Drives Left Ventricular Remodeling After ST Elevation Myocardial Infarction.

Valentina Parisi, Serena Cabaro, Vittoria D'Esposito, Laura Petraglia, Maddalena Conte, Pasquale Campana, Gerardo Gerundo, Marianna Abitabile, Andrea Tuccillo, Maria Accadia and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Interleukin 4/13 signaling in cardiac regeneration and repair.American journal of physiology. Heart and circulatory physiology · 2022
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Emerging role of interleukin-13 in cardiovascular diseases: A ray of hope.Journal of cellular and molecular medicine · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Valentina ParisiDepartment of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
Serena CabaroDepartment of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
Vittoria D'EspositoDepartment of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
Laura PetragliaDepartment of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
Maddalena ConteDepartment of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
Pasquale CampanaDepartment of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
Gerardo GerundoDepartment of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
Marianna AbitabileDepartment of Emergency Medicine, Ospedale del Mare, Naples, Italy.
Andrea TuccilloDepartment of Cardiology, Ospedale del Mare, Naples, Italy.
Maria AccadiaDepartment of Cardiology, Ospedale del Mare, Naples, Italy.
Giuseppe ComentaleDepartment of Advanced Biomedical Science, University of Naples Federico II, Naples, Italy.
Emanuele PilatoDepartment of Advanced Biomedical Science, University of Naples Federico II, Naples, Italy.
Mario SansoneDepartment of Electrical Engineering and Information Technology, University of Naples Federico II, Naples, Italy.
Dario LeoscoDepartment of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
Pietro FormisanoDepartment of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
University of Naples Federico II · ITInstitute for Experimental Endocrinology and Oncology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLeft ventricular (LV) remodeling after ST-segment elevation myocardial infarction (STEMI) is explained only in part by the infarct size, and the inter-patient variability may be ascribed to different inflammatory response to myocardial injury. Epicardial adipose tissue (EAT) is a source of inflammatory mediators which directly modulates the myocardium. EAT increase is associated to several cardiovascular diseases; however, its response to myocardial injury is currently unknown. Among inflammatory mediators, IL-13 seems to play protective role in LV regeneration, but its variations after STEMI have not been described yet. Purpose: In the present study we analyzed the association between infarct-related changes of EAT and IL-13 in post-STEMI LV remodeling.

methodsWe enrolled 100 patients with STEMI undergoing primary angioplasty. At the enrolment (T0) and after 3 months (T1), we measured EAT thickness by echocardiography and circulating levels of IL-13 by ELISA.

resultsAt T1, the 60% of patients displayed increased EAT thickness (ΔEAT > 0). ΔEAT was directly associated to LV end-diastolic volume (

conclusionThe variability of STEMI-induced "inflammatory response" may be associated to the post-infarct LV remodeling. ΔEAT thickness and ΔIL-13 levels could be novel prognostic markers in STEMI patients.

Indexed as

biomarkerscytokinesechocardiographyepicardial adipose tissueinflammationleft ventricular remodeling

Identifiers

PMID33178043
PMCPMC7593695
OpenAlexW3092799841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.